Dexcom Secures Future in Europe, Middle East, and Africa by Breaking Ground on New Manufacturing Facility in Ireland
19 Enero 2024 - 1:00AM
Business Wire
- Dexcom’s first manufacturing facility in Europe will ensure the
flow of products throughout EMEA
- New manufacturing site will create over 1,000 local jobs,
including across finance, HR and engineering disciplines
DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time
continuous glucose monitoring (rtCGM) for people with diabetes, has
officially broken ground on its new state-of-the-art manufacturing
facility, located in Athenry, Co. Galway. This marks the first step
in the realisation of this facility, which will bring more than
1,000 jobs to the area and represents one of the biggest single
private sector investments ever in the West of Ireland.
Dexcom’s first manufacturing facility in Europe will ensure the
flow of products throughout EMEA, with the potential to lower the
cost of goods and improve sustainability by decreasing delivery
time in transit. The new facility will have the capacity to produce
millions of Dexcom rtCGM sensors each year, helping to improve the
lives of people with diabetes in EMEA.
“This facility is strategically located in Europe, for Europe,”
said Alex Moussa, Senior Vice President & General Manager EMEA
and LATAM at Dexcom. “This development demonstrates our commitment
to sustainable growth and operational excellence in EMEA, as well
as to the people we serve. This is only the beginning; we’re truly
excited for what’s to come.”
The 1,000 available jobs include support in finance, HR, as well
as a variety of engineering roles, ranging from leadership to
graduate positions. Dexcom intends to build strong links with the
local universities in Galway and nearby counties, particularly
around engineering and quality assurance courses. In an additional
boost to the local economy, it is expected that for every job
created by Dexcom a further 1 – 1.7 jobs will be created
indirectly*.
“At Dexcom, we pride ourselves on attracting and retaining
world-class talent, which Ireland provides,” said Simone Würzner,
Senior Director Human Resources EMEA. “As an organisation, we
empower people to better manage their health with our life-changing
continuous glucose monitoring technology. The opportunity this
provides to our team is endless, offering challenging and
meaningful work that truly makes a difference in people’s lives.
We’re looking forward to building our team in Ireland as we enter
the next phase of Dexcom in Europe.”
Dexcom is also further demonstrating its long-term commitment to
Europe, and specifically the West of Ireland by announcing a
12-year naming-rights partnership with Connacht Rugby. From today,
‘The Sportsground’ will be known as ‘Dexcom Stadium,’ which has
been the home of Connacht Rugby since 1927. For information about
Dexcom job openings in Athenry go to:
careers.dexcom.com/careers.
To learn more about Dexcom or to get started with Dexcom CGM
today, visit Dexcom.com.
About DexCom, Inc.
DexCom, Inc. empowers people to take real-time control of health
through innovative continuous glucose monitoring (CGM) systems.
Headquartered in San Diego, Calif., and with operations across
Europe, Dexcom has emerged as a leader of diabetes care technology.
By listening to the needs of users, caregivers, and providers,
Dexcom works to simplify and improve diabetes management around the
world. For more information about Dexcom CGM, visit
www.dexcom.com.
*Statistic provided by IDA
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240118076158/en/
Kate Lynch, Allison for Dexcom
Kate.Lynch@allisonworldwide.com
DexCom (NASDAQ:DXCM)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
DexCom (NASDAQ:DXCM)
Gráfica de Acción Histórica
De May 2023 a May 2024